ボラージ種子油と月見草油の比較:GLA、安全性、ソフトジェルガイド

Borage seed oil usually contains more gamma-linolenic acid (GLA) per gram than evening primrose oil, so it may reach the same formulated GLA amount with less oil. That does not prove stronger clinical effects. Borage oil also needs documented pyrrolizidine alkaloid control, while both oils require fatty-acid, oxidation, contaminant and stability specifications.

This guide is for consumers, formulators, supplement brands and procurement teams comparing these oils for softgels or other dietary supplement products. It does not present either oil as a treatment for eczema, PMS, menopause, arthritis, asthma, diabetes, weight loss or another medical condition.

Borage seed oil vs evening primrose oil comparison by GLA, PA safety and softgel use

Borage Seed Oil vs Evening Primrose Oil at a Glance

ファクターボラージシードオイル月見草オイル
植物由来ボラゴ・オフィシナリス seed; also marketed as スターフラワー油オオエノテラ
Typical GLA specificationOften approximately 18%–26%, depending on cultivar, process and lot specificationOften approximately 7%–10%, depending on cultivar, process and lot specification
Oil required for the same GLA targetUsually lessUsually more
Distinctive safety/quality issueDocumented control and testing of relevant pyrrolizidine alkaloidsNo borage-specific PA issue, but normal identity, oxidation and contaminant controls still apply
Commercial advantageHigher GLA concentration can reduce fill weightStrong consumer recognition and established market positioning
Key formulation risksPA documentation, oxidation, source variation, odor and softgel stabilityOxidation, GLA variability, larger fill weight and softgel stability

What Is Borage Seed Oil?

Borage seed oil is extracted from the seeds of ボラゴ・オフィシナリス. Starflower oil is a common market name for the same seed oil. Its main formulation value is its relatively high GLA content.

In supplement specifications, “borage oil” should identify the botanical name, seed as the plant part, extraction and refining process, country of origin, fatty-acid profile and lot-specific quality results. It should not be confused with borage leaf, flower or crude herbal preparations.

月見草オイルとは?

月見草 oil is extracted from the seeds of オオエノテラ. It contains linoleic acid and a smaller GLA fraction than most commercial borage seed oils. It is widely sold in liquid oil and softgel formats.

Consumer familiarity does not establish effectiveness for a health condition. The finished product still requires a verified fatty-acid profile, oxidation controls, stability data and claims review.

Is Borage Oil the Same as Starflower Oil?

Yes. “Starflower oil” commonly refers to borage seed oil. A marketing name is not enough for purchasing, however. Procurement documents should still specify ボラゴ・オフィシナリス, seed oil, extraction/refining process and the required GLA and PA specifications.

GLA Content: Why Percentage Alone Is Not Enough

A higher GLA percentage means that less total oil may be needed to deliver the same formulated GLA amount. It does not prove that the oil works faster, produces stronger clinical outcomes or is better for a specific disease.

Formulation ExampleOil at 20% GLAOil at 9% GLA
100 mg formulated GLA500 mg oilApproximately 1,111 mg oil
200 mg formulated GLA1,000 mg oilApproximately 2,222 mg oil
Softgel implicationPotentially smaller fill or fewer unitsLarger fill or more units may be required

These calculations are formulation examples, not consumer dose recommendations. Use the actual lot-specific fatty-acid result and account for overages, fill-weight tolerance, serving count and shelf-life changes.

Oil fill needed for the same GLA amount from borage and evening primrose oil

Which Oil Is Better for Each Product Goal?

製品目標Likely Starting Option理由
Higher GLA in a smaller oil fillBorage seed oil with qualified PA documentationHigher GLA concentration may reduce total fill weight
Familiar consumer-facing women’s wellness softgel月見草オイルEstablished ingredient recognition, subject to conservative claims
Low-oxidation premium softgelEither oil meeting the full oxidation and stability specificationFreshness and packaging are more important than the ingredient name alone
PA-sensitive market or buyerEvening primrose oil, or borage oil with validated lot-level PA resultsReduces ambiguity in supplier qualification
Combined GLA oil formulaOnly with a clear formulation rationaleCombining similar oils may duplicate GLA without adding meaningful differentiation

エビデンスと健康強調表示の境界

Skin and Eczema

Oral evening primrose oil and borage oil have been studied for eczema, but a Cochrane review found no clinically useful benefit compared with placebo. Do not market either oil as an eczema, psoriasis, rosacea or acne treatment.

PMS, Menopause and “Hormone Balance”

Evening primrose oil is frequently marketed for PMS and menopause, but authoritative reviews describe the evidence as insufficient or inconclusive. “Balances hormones” is vague and may imply treatment. Use only specific, substantiated structure/function language.

Inflammation, Joints and Other Conditions

GLA participates in fatty-acid metabolism, but that fact alone does not support claims to treat arthritis, asthma, neuropathy, chronic pain or cardiovascular disease. Research must match the exact ingredient, dose, population and finished formula.

Weight and Estrogen Questions

Neither oil is established as a weight-loss, belly-fat or estrogen-increasing supplement. These questions should be answered directly without suggesting a predictable hormonal or body-composition effect.

Safety: Pyrrolizidine Alkaloids and Borage Oil

Borage plants can contain toxic unsaturated pyrrolizidine alkaloids. Processing and refining can reduce contaminants, but “PA-free” should not be accepted as an undefined sales phrase. Buyers need a method, analyte panel, reporting limit and lot-specific result.

  • Specify the target PA and PA-N-oxide analytes included in the panel.
  • Request the analytical method and validation or laboratory scope.
  • Record the limit of detection and limit of quantification.
  • Require a lot-specific numerical result or clearly defined “not detected” result.
  • Match the release specification to the target market and intended daily exposure.
  • Maintain traceability from seed source through refined oil and finished product.

Brands sourcing oil can review a qualified borage oil ingredient specification, but the actual purchase decision must use current batch documents rather than website language.

General Safety and Interaction Review

  • Both oils may cause gastrointestinal effects such as nausea, loose stools or abdominal discomfort.
  • People taking prescription medicines, especially medicines affecting bleeding or seizure control, should ask a healthcare professional before use.
  • Pregnancy and breastfeeding require product-specific professional review; do not rely on a generic “safe” statement.
  • People with liver disease, seizure disorders, upcoming surgery or complex medical conditions should seek individualized advice.
  • Combining the two oils may duplicate GLA exposure without proven additional benefit.

ソフトジェル製剤に関する考慮事項

Both oils fit 液体充填式 softgel systems. A higher GLA percentage can reduce fill weight, but oxidation control and shell compatibility determine whether the product remains stable and acceptable.

  • Verify the lot-specific fatty-acid profile and GLA percentage.
  • Set peroxide value, p-anisidine value and TOTOX limits where appropriate.
  • Review acid value, moisture, odor, color and clarity.
  • Define antioxidant additions and processing aids.
  • Control oxygen exposure with suitable handling, nitrogen and headspace strategy.
  • Test shell-fill compatibility, leakage, seam quality and migration.
  • Use light- and oxygen-barrier packaging.
  • Run real-time and accelerated stability in the final package.

For dosage-form development, see GENSEI’s ソフトジェルカプセルの製造 機能。.

Borage and evening primrose oil softgel oxidation, filling and stability controls

品質仕様チェックリスト

品質部門確認すべき事項なぜ重要なのか
植物学的同定Species, seed as plant part, origin and processConfirms the correct ingredient
脂肪酸組成GLA, linoleic acid, oleic acid and other major fatty acidsVerifies identity and formulated potency
ボラージのPA制御Method, analytes, LOD/LOQ, lot result and release limitControls the distinctive borage safety risk
酸化Peroxide value, p-anisidine value and TOTOX where appropriateSupports freshness and shelf-life decisions
Other contaminantsPesticides, heavy metals, residual solvents and microbiology as applicableSupports ingredient release and market compliance
物理的性質Color, odor, clarity, density and viscosityAffects filling, sensory quality and consistency
Added materialsTocopherols, antioxidants, carriers and processing aidsEnsures complete formula and label review
ドキュメントLot COA, specification, TDS/SDS, traceability and change controlSupports supplier qualification and audit readiness
Finished productFill weight, leaks, disintegration, stability and packaging compatibilityRaw-oil quality alone does not assure softgel quality

Connect raw-material release criteria to finished-product サプリメント品質管理 and documented change-control procedures.

石油供給業者またはソフトジェル製造業者向けのRFPに関する質問

  1. What botanical species, plant part and country of origin apply?
  2. Is the oil cold-pressed, solvent-extracted, refined, deodorized or otherwise processed?
  3. What minimum and typical GLA percentages are guaranteed?
  4. Can you provide three recent lot-specific fatty-acid profiles and COAs?
  5. For borage oil, which PA and PA-N-oxide analytes are tested?
  6. What method, laboratory, LOD, LOQ and release limit are used for PA testing?
  7. What are the peroxide, p-anisidine, TOTOX and acid-value specifications?
  8. Which antioxidants, carriers or processing aids are present?
  9. What pesticide, heavy-metal, residual-solvent and microbiological tests are included?
  10. What packaging, storage and shelf-life conditions are supported?
  11. What are the MOQ, sample quantity, lead time and change-control terms?
  12. Can the manufacturer support pilot softgels and final-package stability?
  13. How are skin, women’s-health, inflammation and hormone-related claims reviewed?

よくある質問

ボラージオイルと月見草オイル、どちらが良いですか?

Borage oil is usually more concentrated in GLA and may require less oil for the same formulated GLA amount. Evening primrose oil may be preferred for consumer familiarity. The better ingredient is the one that meets the required safety, oxidation, stability and documentation specifications.

ボラージオイルと月見草オイルを一緒に飲んでもいいですか?

They provide overlapping fatty acids, so combining them may duplicate GLA exposure without proven additional benefit. A healthcare professional should review the total formula and medicines.

ボラージオイルはエストロゲンを増やすのでしょうか?

There is no reliable evidence that borage oil predictably increases estrogen. Do not market it as a hormone treatment.

ボラージオイルは体重増加の原因になりますか?

No good evidence shows a specific weight-gain effect. Like all oils, it provides calories, but body weight depends on the overall diet and many other factors.

「PAフリーのボラージオイル」とは、どういう意味なのでしょうか?

It should mean that a defined analytical panel was tested using a documented method and reporting limit, with a lot-specific result that meets the buyer’s release specification. A marketing phrase alone is insufficient.

Is cold-pressed oil always better?

No. Cold pressing may support a particular source story, but refining or deodorization may be needed to control odor, contaminants or stability. Quality should be judged by the complete specification and batch results.

最終的な収穫

Borage seed oil and evening primrose oil are both GLA-containing seed oils, but a higher GLA percentage is a formulation advantage—not proof of superior clinical results. Responsible selection requires verified fatty-acid profiles, PA control for borage oil, oxidation limits, softgel compatibility, final-package stability and conservative claims.

ブランドは GENSEIへのお問い合わせ with the target GLA amount, PA specification, dosage form, package, market and order quantity to request a sample, COA or quotation.

参考文献

  1. NCCIH:月見草オイル――有用性と安全性
  2. NCCIH: Skin Conditions and Complementary Health Approaches—What the Science Says
  3. PubMed: Oral Evening Primrose Oil and Borage Oil for Eczema—Cochrane Review
  4. EMA: Pyrrolizidine Alkaloids in Herbal Medicinal Products—Scientific Guideline
  5. EFSA:食品中のピロリジジンアルカロイドが人の健康に及ぼすリスク
  6. FDA:構造・機能に関する主張
  7. FTC:健康関連製品のコンプライアンスに関するガイダンス
  8. 21 CFR 第111部:栄養補助食品の適正製造規範(cGMP)
トップに戻る